Health Canada has issued a strong warning against the purchase and use of unauthorized or counterfeit GLP-1 drugs, including the widely recognized semaglutide, an active ingredient...
Eli Lilly has announced a reduction in the price of its obesity treatment, Zepbound, to enhance affordability for U.S. patients. Starting immediately, patients with a prescription...
Eli Lilly has announced a significant reduction in the prices of its obesity treatment, Zepbound, aiming to increase accessibility for U.S. patients. As of March 2024,...